Symbiotec Pharmalab IPO

The Symbiotec Pharmalab IPO opens on 24 Aug 2026 and closes on 27 Aug 2026. Check this page for the latest updates as we refresh every 30 minutes.

The price band for the Symbiotec Pharmalab IPO is ₹938 to ₹988. The final price is announced after the book-building process and is confirmed before listing.

The minimum lot size is TBA shares with a minimum investment of not yet announced. Retail investors can apply for up to the retail limit defined by SEBI.

Grey Market Premium data for Symbiotec Pharmalab is not available yet. It typically starts appearing a few days before the IPO opens.

The Symbiotec Pharmalab IPO is expected to list on 01 Sep 2026 on BSE, NSE. Actual listing day trading begins at the start of the normal market session.

You can check your allotment status on the registrar's portal using your PAN, application number, or DP ID. We link to the registrar directly on our allotment page after the allotment date.

Symbiotec Pharmalab is a mainboard IPO that will list on the main NSE and BSE boards. Mainboard IPOs are open to retail investors with a minimum application of one lot.

You can apply for the Symbiotec Pharmalab IPO through any SEBI-registered broker such as Zerodha, Upstox, or Angel One using UPI or ASBA. Use the Apply Now buttons on this page to go directly to the broker.

Based on our algorithmic analysis, Symbiotec Pharmalab IPO is rated UNRATED with low confidence. Rating will be available once subscription and GMP data is collected. This is not investment advice — please read the DRHP and consult a financial advisor before investing.